Dergiler / Turkish Neurosurgery / 2017 / Cilt: 27 - Sayı: 6

Differences in Protein Expression between the U251 and U87 Cell Lines

Sayfa
894–903
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Further studies on these pathways may identify whether these various pathways account for the observed phenotype differences between the U87 and U251 GBM cell lines

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIm: The U251 and U87 cell lines are commonly used as experimental models of glioblastoma.
📊
Temel Bulgular & Veri:However, these cells exhibit significant differences in their proliferation, invasion, and migration.
💡
Sonuç & Katkı:Further studies on these pathways may identify whether these various pathways account for the observed phenotype differences between the U87 and U251 GBM cell lines
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

AIm: The U251 and U87 cell lines are commonly used as experimental models of glioblastoma. However, these cells exhibit significant differences in their proliferation, invasion, and migration. The aim of the present study was to compare the protein expression profiles of the U251 and U87 cell lines in order to provide a molecular basis for the observed phenotypic differences. mATERIAl and mEThODS: Isobaric tags for relative and absolute quantitation (iTRAQ) and gene ontology (GO) analyses were performed to detect differentially expressed proteins and to predict protein functions, respectively. RESUlTS: Two hundred and forty-four proteins were highly expressed, while 263 proteins exhibited lower levels of expression, in the U251 cells compared to the U87 cells. In particular, higher expression levels of the proteins, C10orf58, FLNC, PDLIM1, TPM4, and lower expression levels of MYH10, PSIP1, SYNM, SLC9A3R2, BCAM, were verified by qPCR in the U251 cell line versus the U87 cell line. When a GO analysis was applied to the iTRAQ results, the proteins that were highly expressed in the U251 cells were found to differ in their molecular functions, biological processes, cellular distribution, and cellular pathways associated with them compared with the highly expressed proteins detected in the U87 cells. CONClUSION: Differentially expressed proteins between the U251 and U87 cell lines are associated with regulation of nicotinamide nucleotide metabolism, RNA splicing, glycolysis, and purine metabolism pathways. Further studies on these pathways may identify whether these various pathways account for the observed phenotype differences between the U87 and U251 GBM cell lines

🔖

Bu Makaleye Atıf Yap

LIU, Y., QI, S., FENG, W., WANG, H., LEİ, B., XIANG, W., Lİ, H. (2017). Differences in Protein Expression between the U251 and U87 Cell Lines. Turkish Neurosurgery, Cilt: 27 - Sayı: 6, 894–903. https://ajindex.com/articles/404549

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Allison AC, Eugui EM: The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 14:353-380, 1993 2. Arif T, Vasilkovsky L, Refaely Y, Konson A, Shoshan-Barmatz V: Silencing VDAC1 expression by siRNA inhibits cancer cell proliferation and tumor growth in vivo. Mol Ther Nucleic Acids 3: 159, 2014 3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000 4. Beckman G, Beckman L, Ponten J, Westermark B: G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines: Evidence against cross-contamination and contamination by HeLa cells. Hum Hered 21:238-241, 1971 5. Di Stefano G, Manerba M, Vettraino M: NAD metabolism and functions: A common therapeutic target for neoplastic, metabolic and neurodegenerative diseases. Curr Top Med Chem 13:2918-2929, 2013 6. Fairbanks LD, Ruckemann K, Qiu Y, Hawrylowicz CM, Richards DF, Swaminathan R, Kirschbaum B, Simmonds HA: Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: A metabolic basis for efficacy in rheumatoid arthritis? Biochem J 342 (Pt 1):143-152, 1999 7. Gandhi V, Kilpatrick JM, Plunkett W, Ayres M, Harman L, Du M, Bantia S, Davisson J, Wierda WG, Faderl S, Kantarjian H, Thomas D: A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). Blood 106:4253-4260, 2005 8. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408, 2001 9. Lu Y, Xiao L, Liu Y, Wang H, Li H, Zhou Q, Pan J, Lei B, Huang A, Qi S: MIR517C inhibits autophagy and the epithelialto-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation. Autophagy 11:2213-2232, 2015 10. Mi H, Muruganujan A, Thomas PD: PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res 41:D377-D386, 2013 11. Mikawa T, LLeonart ME, Takaori-Kondo A, Inagaki N, Yokode M, Kondoh H: Dysregulated glycolysis as an oncogenic event. Cell Mol Life S